Opiant Pharmaceuticals to Report Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11, 2022
August 01 2022 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ:
OPNT), a specialty pharmaceutical company developing medicines to
treat addictions and drug overdose, today announced it will
report its financial results for the second quarter ended June 30,
2022, after the financial markets close on Thursday, August
11, 2022.
The Company’s management team is scheduled to host a conference
call and webcast at 4:30 p.m. ET on Thursday, August
11, 2022. To access the call, please dial 1-877-407-0792 in
the U.S. or 1-201-689-8263 outside the U.S. and
provide the conference ID number: 13730815. To access the live
webcast, please visit
https://viavid.webcasts.com/starthere.jsp?ei=1556372&tp_key=6cb19180df.
Following the live webcast, an archived version of the call will be
available on the website.
Thursday August 11 @ 4:30 pm
ET
Domestic: |
1-877-407-0792 |
International: |
1-201-689-8263 |
Conference ID: |
13730815 |
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1556372&tp_key=6cb19180df |
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose. For more information
visit: www.opiant.com.
For Media and Investor Inquiries:Ben Atkins,
Opiant(310) 598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Apr 2023 to Apr 2024